O'Shaughnessy Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,713	Closed	-$8K	–	927
2016 Q1	$8K	Sell	1,713 -309	-15%	-$1.47K	﹤0.01%	765
2015 Q4	$11K	Sell	2,022 -373	-16%	-$2.13K	﹤0.01%	719
2015 Q3	$14K	Buy	2,395 +474	+25%	+$2.95K	﹤0.01%	672
2015 Q2	$14K	Buy	1,921 +733	+62%	+$5.1K	﹤0.01%	706
2015 Q1	$8K	Buy	+1,188	New	+$7.42K	﹤0.01%	762

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

O'Shaughnessy Asset Management's CPIX Position: Q2 2016 in Review

O'Shaughnessy Asset Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2016, closing a stake of 1,713 shares — an estimated $8K sold.

O'Shaughnessy Asset Management first reported a position in CPIX in Q1 2015 and held it in 5 quarters. The position peaked at $14K in Q3 2015. 44 funds tracked by Wall St. Rank hold CPIX as of Q2 2016.

O'Shaughnessy Asset Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
O'Shaughnessy Asset Management sold 1,713 Cumberland Pharmaceuticals shares in Q2 2016, an estimated $8K.
O'Shaughnessy Asset Management first reported a position in Cumberland Pharmaceuticals in Q1 2015 and held it in 5 quarters.
O'Shaughnessy Asset Management's Cumberland Pharmaceuticals position peaked at $14K in Q3 2015.
44 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2016.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2016, filed 11 Aug 2016.